Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. It focuses on advancing a targeted immunotherapy drug candidate, sabirnetug (ACU193), which is i...
Leadership
Daniel J. O'Connell M.B.A.
CEO & Director
James Doherty Ph.D.
President & Chief Development Officer
Matt Zuga
CFO & Chief Business Officer
Grant A. Krafft Ph.D.Founder
Co-Founder
Caleb E. Finch Ph.D.Founder
Co-Founder
William L. Klein Ph.D.Founder
Co-Founder
Russell Barton M.S.
Chief Operating Officer
Kelly Carranza
Senior Vice President of Finance & Accounting and Corporate Controller
